investor_presentation
LiveRamp
Loading viewer...
investor_presentation
Format: PDF investor_presentation
ImmuCell Corporation (NASDAQ: ICCC) presented its investor overview in August 2023, covering company strategy, product portfolio including First Defense and Re-Tain, financial performance, and operational updates. The presentation addresses market opportunities in mastitis treatment while discussing manufacturing capacity expansion and supply chain challenges.
investor_presentation
52 Pages
investor_presentation
20 Pages
AGBA Group Holding Limited
EDP - Energias de Portugal Investor Presentation — September 2020
investor_presentationinvestor_presentation
39 Pages
EDP - Energias de Portugal, S.A.
investor_presentation
LiveRamp